Daves Julie VanOrsdel 4
4 · DiaMedica Therapeutics Inc. · Filed Sep 15, 2022
Insider Transaction Report
Form 4
Daves Julie VanOrsdel
SVP Clinical Development Oper.
Transactions
- Award
Stock Option (right to buy)
2022-09-13+140,000→ 140,000 totalExercise: $1.47Exp: 2032-09-12→ Common Shares (140,000 underlying)
Holdings
- 0
Voting Common Shares, no par value per share
Footnotes (1)
- [F1]This option vests with respect to 35,000 common shares on September 13, 2023 and with respect to the remaining 75% of the common shares in 36 nearly equal monthly installments commencing one month after the one-year anniversary of the grant date.